Experiment 67109
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Crataegus monogyna (ROSACEAE) |
| Citation | TAUCHERT,M: GILDOR,A: LIPINSKI,J:. (1999). HIGH-DOSE CRATAEGUS (HAWTHORN) EXTRACT WS 1442 FOR THE TREATMENT OF NYHA CLASS II HEART FAILURE PATIENTS.. 24(6) |
| Amount utilized | |
| Compound isolated | |
| Disease | FOURTEEN SIDE EFFECTS WERE NOTED IN 1011 PATIENTS. IN TWO CASES (ABDOMINAL DISCOMFORT AND FACIAL PAINS ACCOMPANIED BY TACHYCARDIA) A POSSIBLE RELATIONSHIP WITH THE HAWTHORN THERAPY WAS POSTULATED WHICH HOWEVER WAS CONSIDERED UNLIKELY BY THE TREATING PHYSICIANS. ALMOST 2/3 OF THE PATIENTS FELT BETTER OF MUCH BETTER FOLLOWING THE 24 WKS OF TREATMENT. A COMMERCIAL PRODUCT, CRATAEGUTT FORTE, WAS USED. |
| Dose amount | 900.0 MG |
| Number | 2 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | PROANTHOCYANIDIN FRACTION |
| Gender | GIVEN TO BOTH SEXES |